Analystreport

Emergent BioSolutions Inc. (NYSE: EBS) had its price target lowered by analysts at Chardan Capital from $65.00 to $55.00.

Emergent BioSolutions Inc.  (EBS) 
Last emergent biosolutions inc. earnings: 4/30 04:08 pm Check Earnings Report
US:NYSE Investor Relations: investors.emergentbiosolutions.com